220 related articles for article (PubMed ID: 7669192)
21. Synthesis, antiviral and antiproliferative activity of some N-benzenesulphonyl-2(2- or 3-pyridylethyl)-benzimidazoles.
Garuti L; Roberti M; Rossi T; Cermelli C; Portolani M; Malagoli M; Castelli M
Anticancer Drug Des; 1998 Jul; 13(5):397-406. PubMed ID: 9702206
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines.
Stýskala J; Stýskalová L; Slouka J; Hajdúch M
Eur J Med Chem; 2008 Mar; 43(3):449-55. PubMed ID: 18272255
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and antiproliferative activity in vitro of new 3-substituted aminopyrazolo[3,4-b]pyridines.
Poreba K; Opolski A; Wietrzyk J
Acta Pol Pharm; 2002; 59(3):215-22. PubMed ID: 12230249
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and in vitro antitumor activity of new 1,4-diarylimidazole-2-ones and their 2-thione analogues.
Congiu C; Cocco MT; Onnis V
Bioorg Med Chem Lett; 2008 Feb; 18(3):989-93. PubMed ID: 18164978
[TBL] [Abstract][Full Text] [Related]
25. Antitumor agents. 5. synthesis, structure-activity relationships, and biological evaluation of dimethyl-5H-pyridophenoxazin-5-ones, tetrahydro-5h-benzopyridophenoxazin-5-ones, and 5h-benzopyridophenoxazin-5-ones with potent antiproliferative activity.
Bolognese A; Correale G; Manfra M; Lavecchia A; Novellino E; Pepe S
J Med Chem; 2006 Aug; 49(17):5110-8. PubMed ID: 16913700
[TBL] [Abstract][Full Text] [Related]
26. Antitumor agents. 194. Synthesis and biological evaluations of 4-beta-mono-, -di-, and -trisubstituted aniline-4'-O-demethyl-podophyllotoxin and related compounds with improved pharmacological profiles.
Zhu XK; Guan J; Tachibana Y; Bastow KF; Cho SJ; Cheng HH; Cheng YC; Gurwith M; Lee KH
J Med Chem; 1999 Jul; 42(13):2441-6. PubMed ID: 10395485
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of C8-linked pyrrolo[2,1-c][1,4]benzodiazepine-benzimidazole conjugates with remarkable DNA-binding affinity.
Kamal A; Ramulu P; Srinivas O; Ramesh G; Kumar PP
Bioorg Med Chem Lett; 2004 Sep; 14(18):4791-4. PubMed ID: 15324909
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of some polymethoxylated fused pyridine ring systems as antitumor agents.
Rostom SA; Hassan GS; El-Subbagh HI
Arch Pharm (Weinheim); 2009 Oct; 342(10):584-90. PubMed ID: 19714673
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, in vitro cytotoxic and antiviral activity of cis-[Pt(R(-) and S(+)-2-alpha-hydroxybenzylbenzimidazole)2Cl2] complexes.
Gökçe M; Utku S; Gür S; Ozkul A; Gümüş F
Eur J Med Chem; 2005 Feb; 40(2):135-41. PubMed ID: 15694648
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and preliminary evaluation of selected 2-aryl-5(6)-nitro- 1H-benzimidazole derivatives as potential anticancer agents.
Romero-Castro A; León-Rivera I; Avila-Rojas LC; Navarrete-Vázquez G; Nieto-Rodríguez A
Arch Pharm Res; 2011 Feb; 34(2):181-9. PubMed ID: 21380799
[TBL] [Abstract][Full Text] [Related]
31. Synthesis and cytotoxic activity of 5,6-heteroaromatically annulated pyridine-2,4-diamines.
Willemann C; Grünert R; Bednarski PJ; Troschütz R
Bioorg Med Chem; 2009 Jul; 17(13):4406-19. PubMed ID: 19481463
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and biological evaluation of 2,4-diamino-6-(arylaminomethyl)pyrido[2,3-d]pyrimidines as inhibitors of Pneumocystis carinii and Toxoplasma gondii dihydrofolate reductase and as antiopportunistic infection and antitumor agents.
Gangjee A; Adair OO; Queener SF
J Med Chem; 2003 Nov; 46(23):5074-82. PubMed ID: 14584957
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological investigations of 1-(tetrahydropyran-2'-yl)- and 1-(tetrahydrofuran-2'-yl)benzimidazoles and 1/2-(tetrahydropyran-2'-yl)- and 1/2-(tetrahydrofuran-2'-yl)benzotriazoles.
Sparatore A; Novelli F; Sparatore F
Farmaco; 1997; 52(8-9):509-21. PubMed ID: 9507659
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and anti-tumor activities of some new pyridines and pyrazolo[1,5-a]pyrimidines.
Ahmed OM; Mohamed MA; Ahmed RR; Ahmed SA
Eur J Med Chem; 2009 Sep; 44(9):3519-23. PubMed ID: 19398146
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of 2,6-diaryl-substituted pyridines and their antitumor activities.
Son JK; Zhao LX; Basnet A; Thapa P; Karki R; Na Y; Jahng Y; Jeong TC; Jeong BS; Lee CS; Lee ES
Eur J Med Chem; 2008 Apr; 43(4):675-82. PubMed ID: 17673337
[TBL] [Abstract][Full Text] [Related]
37. Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells.
Alpan AS; Zencir S; Zupkó I; Coban G; Réthy B; Gunes HS; Topcu Z
J Enzyme Inhib Med Chem; 2009 Jun; 24(3):844-9. PubMed ID: 18951286
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and antitumor activity evaluation of 1-[(arylidene)amino]adamantanes.
Chimirri A; Gitto R; Grasso S; Monforte AM; Zappalà M
Farmaco; 1994 Oct; 49(10):649-51. PubMed ID: 7826471
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays.
Coban G; Zencir S; Zupkó I; Réthy B; Gunes HS; Topcu Z
Eur J Med Chem; 2009 May; 44(5):2280-5. PubMed ID: 18692939
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
